Please login to the form below

Not currently logged in
Email:
Password:

Celgene profit up on Revlimid sales

Celgene has reported a jump in second-quarter profits and has increased its earnings forecast for the full year, due mainly to strong sales of Revlimid

Celgene has reported a jump in second-quarter profits and has increased its earnings forecast for the full year, due mainly to strong sales of Revlimid (lenalidomide), the multiple myeloma drug that is derived from thalidomide.

The biotech company's second-quarter net income came in at $155m, or 33 cents a share, compared to $143m, or 31 cents a share, in the second quarter of last year. Revenue jumped to $853m from $629m for the same period in 2009, led mainly by Revlimid sales that rose to $587m from $397m.

The company raised its full-year earnings estimate to between $2.65 and $2.70 a share, up from an earlier forecast of between $2.60 and $2.65 a share. The new estimate represents a 30 per cent increase over full-year 2009. Celgene said it expects revenue for the year to come in somewhere between $3.40bn and $3.45bn, an increase over its earlier forecast of $3.3bn to $3.4bn.

One key reason for the boost in Revlimid sales was a longer duration  of therapy supported by major clinical trial results released at the American Society of Clinical Oncology meeting and elsewhere this year. Other products, including Focalin (dexmethylphenidate) and the Ritalin (methylphenidate) family of drugs for attention deficit-hyperactivity disorder, also performed robustly.

29th July 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...
How Helpful are Simple Health Messages?
...

Infographics